Activist investor Elliott takes stake in drug manufacturer Catalent – source

By Maggie Fick LONDON (Reuters) – Activist investor Elliott Investment has taken a stake in contract drugmaker Catalent, a source familiar with the matter told Reuters on Thursday. The Wall Street Journal reported on Wednesday that Elliott had built a significant stake in Catalent, a New Jersey headquartered, NYSE listed company that does outsourced drug…

Read More

Investors see Japanese equities shining brighter on attractive valuations

By Divya Chowdhury, Anisha Sircar and Lisa Pauline Mattackal MUMBAI (Reuters) – Japanese equities continue to look attractive to foreign and local investors, backed by a significant valuation discount to other developed markets, the continuation of loose monetary policy, and progress made by companies on corporate governance. “We think the land of the rising sun…

Read More

Marsh McLennan beats Q2 profit estimates on interest income boost

(Reuters) – Marsh McLennan reported second-quarter profit above expectations on Thursday, bolstered by the higher interest the company earned from client funds. The company reported a profit of $2.20 per share, excluding one-time costs, for the three months ended June 30. Analysts had expected a profit of $2.12 per share, according to Refinitiv data. Marsh…

Read More

EU imposes sanctions for human rights violations Ukraine, Russia and other countries

BRUSSELS (Reuters) – The European Union said on Thursday it was imposing restrictive measures against 18 individuals and 5 entities for human rights violations in Afghanistan, South Sudan, Central African Republic, Ukraine and Russia. The Taliban ministers of Education and Justice as well as the acting Taliban Chief Justice of the Afghanistan Supreme Court are…

Read More

Ryanair pledges to base 30 new aicraft in Ukraine after conflict ends

DUBLIN (Reuters) – Ryanair said on Thursday it plans to base up to 30 new Boeing 737 MAX aircraft at Ukraine’s three main airports and fly over five million passengers a year when fighting eventually ends. The airline’s statement came as Ryanair Chief Executive Michael O’Leary met Ukraine’s Deputy Prime Minister for Restoration Oleksandr Kubrakov…

Read More

As cell-cultivated meat hits menus, investors see scaling as next hurdle

By Leah Douglas WASHINGTON (Reuters) – Cell-cultivated meat companies could receive new investment since U.S. regulators cleared the product’s sale last month, but the sector must scale up and lower costs to seriously challenge conventional meat, said investors and major food companies. Several startups have developed the technology to grow meat from harvested animal cells,…

Read More